approaches are linked with lipophilicity, molecular weight and H-bonding properties leading to poor aqueous solubility of the newly discovered compounds [6] . As per an estimate, approximately 90% of drug molecules suffer with poor water solubility at early stage, while approximately 40% of the marketed drugs have bioavailability problems mainly due to poor water solubility [7] .
INTRODUCTION
Combinatorial chemistry and high throughput screening techniques have been employed by pharmaceutical industries to hasten their drug discovery and development processes [1, 2] . These techniques have enabled to synthesize and test a very huge number of compounds per day. As a result, a large number of new chemical entities or potential drug candidates are introduced or discovered for a particular diseased condition. However, that is not the end of the process, as further drug development encounters several challenges. Among these are solubility, permeability, stability, safety and efficacy etc. The aforementioned deaccelerate drug development and delay the drug approval process [3] [4] [5] . Among these challenges, poor water solubility of the newly discovered compounds has appeared as the most common challenge in the early drug development, while inefficacy was found as main reason of drug failure in later drug development phases such as phase II. It has been reported that high throughput screening (HTS)-based Current Issues in Pharmacy and Medical Sciences
CONVENTIONAL TECHNIQUES TO IMPROVE SOLUBILITY OF DRUGS
There are several conventional techniques to improve solubility of the drugs as shown in Figure 1 . 
Enhancement in solubility of drugs through salt formation
Improvement of solubility of drug by preparing its salt is a classical technique and can be traced back to the 1970s [21, 22] . As most of the newly discovered drugs are either acidic or basic in nature, these can be converted to their soluble salt forms to enhance water solubility (Table 1) . 
Enhancement in solubility through prodrug approach
The prodrug approach is also one of the classical techniques for solubility enhancement. Prodrugs are inactive compounds consisting of parent drug with or without carrier that are potentiated due to release of active drug in the body through some chemical or enzymatic cleavage. Prodrugs can either be bipartite wherein the drug is directly attached with the carrier or tripartite -containing a spacer between drug and carrier. The inert carriers are commonly attached with the drug by functional groups -amides, carbamates, carbonates, esters, ethers, imines and phosphates, etc. [29] ( Table 2 ). 
Enhancement in solubility through co-solvent approach
The co-solvent approach of enhancing water solubility of poorly soluble drugs involves mixing water-miscible nontoxic organic solvent with water. This improves the solvent action of water, leading to the solublization of poorly soluble drugs. The commonly used co-solvents include ethanol, glycerol, propylene glycol and polyethylene glycols [38] (Table 3) . 
Enhancement in solubility through micellar solublization
The micellar solublization approach is based on the fact that surfactants, owing to their amphiphilic nature, associate spontaneously in anisotropic clusters known as 'micelles'. These contain a hydrophobic center and hydrophilic surfaces. Poorly soluble or water insoluble drugs are enclosed in the hydrophobic centers of micelles, thus become solubilized. It is noteworthy that association or aggregation of surfactant molecules occur at a particular concentration called the 'critical micelle concentration' (CMC). The lower the CMC value of a particular surfactant, the more stable a micelle is formed [45] (Table 4 ). 
Enhancment in solubility through hydrotropic agents
The hydrotropic solublization approach involves the addition of excess hydrotropic agents (hydrophilic inert solutes or polymers) to improve the solubility. Hydrotropic agents are amphiphilic and contain both a hydrophilic head group and a hydrophobic tail group. This is similar to the surfactants, however, herein, the hydrophobic tail is too small to cause spontaneous self-aggregation as observed in micellar solublization. Nevertheless, a unique association (stack-type aggregation) does occur at substantially higher concentrations of hydrotropic agents [55] (Table 5 ). 
Enhancement in solubility through complexation approach
The complexation approach of enhancing drug solubility is a classical and commonly used method. Moreover, this approach is one of the most successful -as evident by several challenging drug products on the market, the solubility of which was improved by complexation. Examples include Prostarmon-E™ sublingual tablets (prostaglandin complexed with cyclodextrin, 1976), Brexin® tablets (Piroxicam complexed with β-CD, 1977) and Sporanox® (itraconazole/2-hydroxypropyl-βCD oral solution) [61, 62] . Inclusion complexes are special kinds of complexes wherein the guest molecule (the hydrophobic drug to be included) fits non-covalently in the inner hydrophobic cavity of the host molecule (the complexing agent). Thus, the poorly soluble hydrophobic drug substance becomes more soluble as it is in a water that contains complexing agents. Complexation of drugs with complexing agents depends on the polarity and size of the host and guest molecule. Cyclodextrins, the cyclic sugars, are the most commonly used complexing agent for the improvement of solubility, owing to the availability of different host molecule cavity sizes [63] (Table 6 ). 
Enhancment in solubility through co-crystal approach
Cocrystals are a crystalline mixture consisting of an active pharmaceutical agent bonded non-covalently with an inactive pharmaceutical agent called a 'conformer' [74] . The advantage of co-crystal enhancement is that any kind of drug, whether acid, base or neutral, can be co-crystallized, unlike salt formations which require that the drug must possess certain characteristics. Cocrystals are high energy forms and are known to increase solubility of the included drugs due to rapid dissociation in the medium, thus creating a supersaturated drug [75] (Table 7 ). 
Enhancment in solubility through solid dispersions
Solid dispersions are amorphous mixtures of solid drug in solid matrix (inactive small molecule or polymer) at molecular levels. Solid dispersions result in supersaturated drug solutions which may precipitate before being absorbed, therefore, components to inhibit drug precipitation should be added into solid dispersions [81] . Fortunately, the most commonly used polymer matrix for solid dispersions, polyvinylpyrrolidone and hydroxypropyl methylcellulose, are known to prevent drug precipitation [81] . The solid dispersion approach is considered a successful and commercially viable method as evidenced by various marketed solid dispersion formulations (Table 8 ). 
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NANOTECHNOLOGY APPROACH TO IMPROVE SOLUBILITY OF DRUGS
Nanotechnology is a recently emerged multidisciplinary scientific technology dealing with objects or materials at nanoscale. It is not a new discipline of science such as physics or chemistry, rather it is a new technology expanding into almost every domain of science, including material sciences, chemical sciences, electronic and health sciences. Nano-medicine and nanotechnology in drug delivery has witnessed a substantial growth in health-care researches owing to its huge potential. In 2014, the global market share was ~41 bn USD and this is expected to reach ~120 bn USD by 2023 [97] . Nano carriers -liposomes, microemulsions, nano-emulsions, nanoparticles, nano-suspensions and nano-crystals -have been investigated to address issues such as poor solubility, poor permeability, instability, and the unsuitable pharmacokinetic profiles of certain existing drugs. The investigation of nano formulations to address specific disease or drug related issues could be traced back to 1970s, however, their application to improve drug solubility has only bee recently approved [98, 99] . The nanofabrication techniques of solubility enhancement (Figure 2) , whether based on lipoid carriers such as fabrication of liposomes, microemulsions, nano-emulsions, or based on polymeric carriers such as fabrication of nanoparticles, nanosuspensions and nano-crystals, generally result in enormous increase in surface area of the fabricated nano-medicines, thereby improving saturated solubility and rate of dissolution [100] .
Liposomes are nano-sized bilayer vesicles of phospholipids that contain hydrophobic bilayer periphery and an aqueous hydrophilic cavity [101] . These are capable of enclosing both hydrophilic, as well as hydrophobic drugs. Microemulsions and nanoemulsions are colloidal emulsions containing a dispersed phase at nano-sized scale. Microemulsions are produced spontaneously by gentle mixing of oil, water and appropriate amounts of emulsifier and coemulsifier [102] . Nanoemulsions, in contrast, are produced with the help of high-energy mixers or homogenizers. Polymeric nanoparticles or nanosuspensions are nanosized drug materials enclosed within a polymeric matrix or shell generally produced by way of utilizing the nanoprecipitation technique. Herein, slow addition of the organic solution of drug and polymer in an antisolvent induces nanoprecipitation and stabilization of the drug after encapsulation within polymeric nanoparticles [103] (Table 9 ). 
CONCLUSIONS
There are several conventional and advanced methods of solubility enhancement. Each method has its own merits and demerits, which need to be considered at the time of selection of the method. Moreover, permeability and stability inside the body are also needed to be considered, as mere solubility enhancement in the laboratory would not be beneficial in real application of improvement of performance of the drug. 
